Breast cancer is the most common malignancy in women all over the world. Genetic
background of women contributes to her risk of having breast cancer. Certain inherited DNA …

Breast cancer is the most common malignancy in women and the leading cause of cancer
deaths in women worldwide. Breast cancers are heterogenous and exist in many different …

Cancer is the most challenging disease of our time with increasing numbers of new cases
each year, worldwide. Great achievements have been reached in cancer research through …

Advances in DNA and RNA sequencing revealed substantially greater genomic complexity
in breast cancer than simple models of a few driver mutations would suggest. Only very few …

Breast cancer is the most commonly occurring cancer in women. There were over two-
million new cases in world in 2018. It is the second leading cause of death from cancer in …

Breast cancer is not a single disease. Genetic array tools can define several subtypes.
Specific biological processes and distinct gene pathways are associated with prognosis and …

Breast cancer is the second most reported cancer in women with high mortality causing
millions of cancer-related deaths annually. Early detection of breast cancer intensifies the …

The genomic revolution has fundamentally changed our perception of breast cancer. It is
now apparent from DNA-based massively parallel sequencing data that at the genomic …

Although the introduction of novel therapies and drug combinations has improved the
prognosis of metastatic breast cancer, this disease remains incurable. It is therefore …

The remarkable advances in next-generation sequencing technology have enabled the
wide usage of sequencing as a clinical tool. To promote the advance of precision oncology …